Congressional Research Service Releases Side-by-side Analysis of User Fee Bills

Posted 01 June 2012 | By

The Congressional Research Service, the House and Senate's semi-private think tank, has released what it is calling a side-by-side comparison of the Senate's Food and Drug Administration Safety and Innovation Act (FDASIA) and the House's Food and Drug Administration Reform Act (FDARA).

The report contains brief summaries of both bills' titles and provisions and how they relate to and alter current laws, particularly the Federal Food, Drug and Cosmetic Act (FD&C Act) and the Public Health Service Act (PHSA).

The 75-page report, released 29 May, is a must-read for all regulatory professionals looking for an in-depth crash course on both pieces of legislation.


Read more:

Side-by-Side Comparison of Current Law, S. 3187 (as passed), Food and Drug Administration Safety and Innovation Act, and H.R. 5651 (suspension document), Food and Drug Administration Reform Act of 2012 (h/t Dickstein Shapiro LLP)


Categories:

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe